Target Price | $5.50 |
Price | $1.69 |
Potential |
225.44%
register free of charge
|
Number of Estimates | 3 |
3 Analysts have issued a price target Akebia Therapeutics, Inc. 2025 .
The average Akebia Therapeutics, Inc. target price is $5.50.
This is
225.44%
register free of charge
$7.50
343.79%
register free of charge
$4.00
136.69%
register free of charge
|
|
A rating was issued by 3 analysts: 3 Analysts recommend Akebia Therapeutics, Inc. to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Akebia Therapeutics, Inc. stock has an average upside potential 2025 of
225.44%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million $ | 194.62 | 172.00 |
33.46% | 11.62% | |
Net Margin | -30.20% | -29.70% |
19.08% | 1.66% |
3 Analysts have issued a sales forecast Akebia Therapeutics, Inc. 2024 . The average Akebia Therapeutics, Inc. sales estimate is
This results in the following potential growth metrics:
3 Akebia Therapeutics, Inc. Analysts have issued a net profit forecast 2024. The average Akebia Therapeutics, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -0.28 | -0.24 |
46.15% | 14.29% | |
P/E | negative | |
EV/Sales | 2.44 |
3 Analysts have issued a Akebia Therapeutics, Inc. forecast for earnings per share. The average Akebia Therapeutics, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Akebia Therapeutics, Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Akebia Therapeutics, Inc....
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.